Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-03-07

FDA Approved: NABUMETONE — Original Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Nabumetone as a generic product under an original ANDA submitted by Exelan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nabumetone (Nabumetone)

Snippet

ORIG AP for NABUMETONE (NABUMETONE)